Does Poorer Pulmonary Function Accelerate Arterial Stiffening?: A Cohort Study With Repeated Measurements of Carotid-Femoral Pulse Wave Velocity

Hypertension
Masaki OkamotoEric J Brunner

Abstract

Whether poorer pulmonary function accelerates progression of arterial stiffness remains unknown as prior observational studies have not examined longitudinal changes in arterial stiffness in relation to earlier pulmonary function. Data (N=5342, 26% female) were drawn from the Whitehall II cohort study. Participants completed repeated assessments of forced expiratory volume in 1 second (FEV1, L) and carotid-femoral pulse wave velocity (cf-PWV, m/s) over 5 years. The effect of FEV1 on later cf-PWV and its progression was estimated using linear mixed-effects modeling. Possible explanatory mechanisms, such as mediation by low-grade systemic inflammation, common-cause explanation by preexisting cardiometabolic risk factors, and reverse-causation bias, were assessed. Poorer pulmonary function was associated with later higher cf-PWV and its subsequent progression (cf-PWV 5-year change 0.09, 95% CI 0.03-0.17 per SD lower FEV1) after adjustment for age, sex, ethnicity, heart rate, and mean arterial pressure. Decrease in pulmonary function was associated with later higher cf-PWV (0.17, 95% CI 0.04-0.30 in the top compared to bottom quartile of decline in FEV1). There was no evidence to support mediation by circulating CRP (C-reactive pro...Continue Reading

References

Jul 15, 1995·BMJ : British Medical Journal·D J Barker
Sep 1, 1995·American Journal of Respiratory and Critical Care Medicine
Mar 15, 1995·American Journal of Epidemiology·X XuS T Weiss
Feb 11, 1999·The New England Journal of Medicine·C Gabay, I Kushner
Dec 26, 2001·American Journal of Respiratory and Critical Care Medicine·M ZureikP Ducimetière
Feb 12, 2004·Arthritis and Rheumatism·A D BoothI B Wilkinson
Mar 6, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology· YasminIan B Wilkinson
Dec 4, 2004·International Journal of Epidemiology·Michael Marmot, Eric Brunner
Jan 14, 2005·Journal of Human Hypertension·C M McEniery, I B Wilkinson
Jan 15, 2005·Clinical and Experimental Pharmacology & Physiology·Kenichiro TanedaKotaro Ozasa
Jul 1, 2005·American Journal of Epidemiology·M Maria GlymourJames M Robins
Sep 27, 2006·European Heart Journal·Stephane LaurentUNKNOWN European Network for Non-invasive Investigation of Large Arteries
Aug 2, 2007·European Journal of Epidemiology·David GimenoJane E Ferrie
Oct 2, 2007·American Journal of Hypertension·Dongliang GeHarold Snieder
Oct 3, 2007·Chest·Robert E WalterEmelia J Benjamin
Apr 24, 2009·Proceedings of the American Thoracic Society·Fernando D Martinez
Mar 27, 2010·Journal of the American College of Cardiology·Charalambos VlachopoulosChristodoulos Stefanadis
Dec 6, 2011·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Carlos A Vaz Fragoso, Thomas M Gill
Mar 17, 2012·Lancet·UNKNOWN Interleukin-6 Receptor Mendelian Randomisation Analysis (IL6R MR) ConsortiumJuan Pablo Casas
Apr 12, 2012·Journal of Epidemiology and Community Health·Anne Kristine GulsvikTorgeir Bruun Wyller
Jun 13, 2012·Journal of Hypertension·Adam Domonkos TarnokiGiuseppe Schillaci
Mar 14, 2013·Respiratory Medicine·David Laszlo TarnokiIldiko Horvath
Jul 31, 2013·Journal of the American Geriatrics Society·Scott D NashMichael Y Tsai
Sep 30, 2014·Epidemiology·G David BattyMika Kivimäki

❮ Previous
Next ❯

Citations

Nov 30, 2019·European Journal of Epidemiology·Marzieh AraghiEric J Brunner
May 9, 2021·Respiratory Medicine·Jenna N McNeillJennifer E Ho

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.